Emmanuel Vial

1.5k total citations
19 papers, 1.1k citations indexed

About

Emmanuel Vial is a scholar working on Molecular Biology, Dermatology and Oncology. According to data from OpenAlex, Emmanuel Vial has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Dermatology and 4 papers in Oncology. Recurrent topics in Emmanuel Vial's work include Melanoma and MAPK Pathways (4 papers), Bone and Dental Protein Studies (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Emmanuel Vial is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Bone and Dental Protein Studies (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Emmanuel Vial collaborates with scholars based in France, United Kingdom and Netherlands. Emmanuel Vial's co-authors include Christopher J. Marshall, Erik Sahai, Marc Castellazzi, Jacques Pouysségur, Raquel García-Medina, Jacques Pouysségur, Hans van Dam, Nicole Montreau, Bernard Binétruy and Curt M. Pfarr and has published in prestigious journals such as The Journal of Cell Biology, Molecular and Cellular Biology and Cancer Cell.

In The Last Decade

Emmanuel Vial

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Vial France 14 675 296 279 150 133 19 1.1k
Sandra Iden Germany 20 890 1.3× 238 0.8× 562 2.0× 116 0.8× 158 1.2× 33 1.7k
Fernando Benavides United States 23 768 1.1× 307 1.0× 212 0.8× 235 1.6× 42 0.3× 61 1.4k
Eun‐Young Shin South Korea 18 614 0.9× 129 0.4× 254 0.9× 110 0.7× 85 0.6× 47 991
Laura Asnaghi United States 20 924 1.4× 230 0.8× 218 0.8× 225 1.5× 86 0.6× 38 1.4k
Charlotte M. Vines United States 19 586 0.9× 328 1.1× 85 0.3× 115 0.8× 117 0.9× 37 1.3k
Benjamin Pierre Bouchet Netherlands 16 929 1.4× 526 1.8× 465 1.7× 214 1.4× 82 0.6× 27 1.5k
Miguel Carballo Spain 27 1.1k 1.6× 104 0.4× 117 0.4× 79 0.5× 46 0.3× 73 1.7k
Muriel Zohar United States 11 786 1.2× 307 1.0× 230 0.8× 193 1.3× 86 0.6× 14 1.2k
Kyoichi Akiyama Japan 14 409 0.6× 125 0.4× 99 0.4× 162 1.1× 140 1.1× 21 913
Corinne Leprince France 16 558 0.8× 109 0.4× 249 0.9× 44 0.3× 119 0.9× 28 1.1k

Countries citing papers authored by Emmanuel Vial

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Vial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Vial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Vial more than expected).

Fields of papers citing papers by Emmanuel Vial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Vial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Vial. The network helps show where Emmanuel Vial may publish in the future.

Co-authorship network of co-authors of Emmanuel Vial

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Vial. A scholar is included among the top collaborators of Emmanuel Vial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Vial. Emmanuel Vial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bertino, Béatrice, Bruno Méhul, Didier Zugaj, et al.. (2018). Brimonidine displays anti‐inflammatory properties in the skin through the modulation of the vascular barrier function. Experimental Dermatology. 27(12). 1378–1387. 12 indexed citations
2.
Aubert, Jacques, David Piwnica, Béatrice Bertino, et al.. (2018). Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene. British Journal of Dermatology. 179(2). 442–456. 50 indexed citations
3.
Rozières, Aurore, Vanina Lenief, Patricia Rossio, et al.. (2017). Topical ivermectin improves allergic skin inflammation. Allergy. 72(8). 1212–1221. 38 indexed citations
4.
Chumakov, Ilya, Serguei Nabirotchkin, Nathalie Cholet, et al.. (2015). Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy. Scientific Reports. 5(1). 7608–7608. 51 indexed citations
5.
6.
Chumakov, Ilya, Aude Milet, Nathalie Cholet, et al.. (2014). Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases. 9(1). 201–201. 71 indexed citations
7.
García-Medina, Raquel, et al.. (2008). Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells. Biochemical and Biophysical Research Communications. 372(4). 845–849. 17 indexed citations
8.
Sahai, Erik, Raquel García-Medina, Jacques Pouysségur, & Emmanuel Vial. (2006). Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. The Journal of Cell Biology. 176(1). 35–42. 152 indexed citations
9.
Vial, Emmanuel & Jacques Pouysségur. (2004). Regulation of Tumor Cell Motility by ERK Mitogen‐Activated Protein Kinases. Annals of the New York Academy of Sciences. 1030(1). 208–218. 80 indexed citations
10.
Briggs, Joseph, Emmanuel Vial, Federico Galvagni, et al.. (2003). v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3. Oncogene. 22(26). 4047–4061. 28 indexed citations
11.
Vial, Emmanuel, Erik Sahai, & Christopher J. Marshall. (2003). ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell. 4(1). 67–79. 335 indexed citations
12.
Vial, Emmanuel & Christopher J. Marshall. (2003). Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. Journal of Cell Science. 116(24). 4957–4963. 100 indexed citations
13.
Bost, Frédéric, Leslie Caron, Emmanuel Vial, et al.. (2001). The defective transforming phenotype of c-Jun Ala63/73 is rescued by mutation of the C-terminal phosphorylation site. Oncogene. 20(50). 7425–7429. 5 indexed citations
14.
Vial, Emmanuel, et al.. (2001). Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation. Oncogene. 20(9). 1135–1141. 54 indexed citations
15.
16.
Vial, Emmanuel, et al.. (2000). Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors. Oncogene. 19(43). 5020–5029. 30 indexed citations
17.
Vandel, Laurence, Nicole Montreau, Emmanuel Vial, et al.. (1996). Stepwise Transformation of Rat Embryo Fibroblasts: c-Jun, JunB, or JunD Can Cooperate with Ras for Focus Formation, but a c-Jun-Containing Heterodimer Is Required for Immortalization. Molecular and Cellular Biology. 16(5). 1881–1888. 54 indexed citations
18.
Vial, Emmanuel, et al.. (1983). Source of the Colours Produced in Tissue Slices with the MBTH Reaction Colour Sources. Cells Tissues Organs. 115(3). 238–243.
19.
Vial, Emmanuel, et al.. (1980). Observations on the Histogenesis of Bovine Ruminal Papillae. American Journal of Veterinary Research. 41(2). 174–178. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Iden Breakdown of academic impact, for papers by Fernando Benavides Breakdown of academic impact, for papers by Eun‐Young Shin Breakdown of academic impact, for papers by Laura Asnaghi Breakdown of academic impact, for papers by Charlotte M. Vines Breakdown of academic impact, for papers by Benjamin Pierre Bouchet Breakdown of academic impact, for papers by Miguel Carballo Breakdown of academic impact, for papers by Muriel Zohar Breakdown of academic impact, for papers by Kyoichi Akiyama Breakdown of academic impact, for papers by Corinne Leprince
Rankless by CCL
2026